Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News Symic Bio initiates SB-030 Phase 1/2a study in peripheral artery disease Symic Bio, a biopharmaceutical company based in California specializing in matrix biology, is set to commence a phase… bypharmanewsdailyFebruary 25, 2017